Navigation Links
Pharmos Corporation Reports 2008 Third Quarter Results
Date:11/6/2008

result from non recurring 2007 costs related to contractual payment obligations associated with the retirement of the Company's chief executive officer, higher legal and accounting fees in 2007, a one time IRS section 382 tax analysis cost incurred in 2007, a non recurring recruitment fee of $42,000 in 2007 and higher BOD meeting costs in 2007.

The company believes that the current cash and cash equivalents totaling $6.1 million as of September 30, 2008 will be sufficient to support the currently planned continuing operations through at least December 31, 2008. The company is actively pursuing efforts to raise additional capital but there can be no assurance that such efforts will be successful.

About Pharmos Corporation

Pharmos discovers and develops novel therapeutics to treat a range of indications including specific diseases of the nervous system such as disorders of the brain-gut axis (GI/IBS), pain/inflammation, and autoimmune disorders. The Company's lead product in development, dextofisopam, is undergoing Phase 2b testing in IBS patients. Dextofisopam has completed a Phase 2a IBS study in which it demonstrated a statistically significant effect compared to placebo on the primary efficacy endpoint of adequate relief (n=141, p=0.033). The Company also has a proprietary technology platform focusing on discovery and development of synthetic cannabinoid compounds with a focus on CB2 receptor selective agonists. Various CB2-selective compounds from Pharmos' pipeline have completed preclinical studies targeting pain, multiple sclerosis, rheumatoid arthritis, inflammatory bowel disease and other disorders. Pharmos is also working to commercialize its proprietary NanoEmulsion drug delivery system, which is in clinical-stage development for topical application of analgesic and anti-inflammatory agents.

Safe Harbor Statement

Statements made in this press release related to the business outlook and future financial performance of Phar
'/>"/>

SOURCE Pharmos Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Pharmos Restructures Operations in Israel
2. Pharmos Corporation Reports 2007 Fourth Quarter and Year-end Results
3. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
4. Brooke Franchise Corporation Announces Selected July Results
5. MedThink Communications Retained by NanoBio Corporation
6. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
7. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
8. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
9. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
10. LifeQuest World Corporation Proud Contributor to Dietary Supplement Education Alliance (DSEA)
11. DTI Medical Corporation Announces Reverse Split and Other Corporate Developments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... are challenging and unpredictable times for traditional organizations across ... are rewriting the rules for business as we knew ... businesses to take on a more agile approach in ... On top of this there is a growing trend ... new innovation and approaches to business. , The manager ...
(Date:6/3/2015)... Hills, Calif. (PRWEB) June 03, 2015 ... most popular boot camp fitness program. The company helps thousands ... healthier lives. To encourage more people to hit the gym ... released these five tips for getting the most out any ... The hardest part about committing to gym memberships is saying ...
(Date:6/3/2015)... June 03, 2015 evigilo, a ... multi-channel solutions, reported of its "behind-the-scenes" involvement in ... few months. Since March this year, an unusual ... inflicting the South-American country, putting millions in danger. ... gas into the atmosphere. "evigilo's technology, adopted by ...
(Date:6/2/2015)... 03, 2015 The JK-A0100EU secure smart ... as government, finance and healthcare. However, this keyboard can ... access control to enhance the security of their network. ... secondary authentication of a Smart Card before allowing access ... smart-chipset card reader, the keyboard supports secure PIN entry. ...
(Date:6/2/2015)... June 02, 2015 April 8th, 2015, ... venue into Durkin Entertainment’s “RockNRolla Movie Awards” EcoLuxe Lounge, ... that gathered some of the world’s top providers of ... event was organized by Debbie Durkin, Los Angeles’ leading ... the EcoLuxe Lounge is a premier red carpet event ...
Breaking Medicine News(10 mins):Health News:Chief Digital Officer of Travelex joins Bayer, Abellio and Just Eat at The Open Mobile Summit London 2Health News:Summer Body Slim-Down: 5 Ways to Avoid Quitting Gym Memberships this Summer 2Health News:Summer Body Slim-Down: 5 Ways to Avoid Quitting Gym Memberships this Summer 3Health News:Thousands of Lives Saved, Millions Protected in Chile 2Health News:Introducing the New CHERRY JK-A0100EU Keyboard with Integrated Smart Card Reader for Access Control Security 2Health News:Choices Recovery South Bend Discusses Addiction With Rising Hollywood Star Ben Stillwell 2
... try to emulate,others, lifestyles, adopt someone,s new fad ... in frustration and failure," writes Larry G.,Patten. "These ... own idea of great,health.", In "Champion Health" ... offering in his Champion Series of,self-improvement books, Patten ...
... see modest tie between displeasure, peripheral artery disease ... Sexual dissatisfaction in postmenopausal women isn,t associated with ... that sexual dysfunction in some men is predictive ... been examined in women. , In this study, ...
... Health Care Quality Act, Would Save Thousands of Lives,Billions ... top companies joined forces Wednesday, April 2, 2008, with ... "Wired for Health Care,Quality Act," a measure to bring ... To view the Multimedia News Release, go to:, ...
... /Xinhua-PRNewswire-FirstCall/ -- China,Nepstar Chain Drugstore Ltd. (NYSE: ... drugstore chain in China based on the number ... been awarded the,title of "Best Drugstore Chain of ... trade publication in the Drugstore industry in China., ...
... The undersigned,organizations from around the state are releasing ... candidates campaigning here now,to draw attention to Pennsylvania,s efforts ... HB 2098 and HB 2005., An Open Letter, ... Senator Obama:, Healthcare has been central to each ...
... /PRNewswire-FirstCall/ - Haemacure Corporation (TSX,: HAE), a ... protein products for commercialization,disclosed today the results ... on,the use of its proprietary lead product ... the formation of post-surgical adhesions., The ...
Cached Medicine News:Health News:'Champion Health': Learn How to Create a Unique, Personalized Health Plan That Works and Keeps Working 2Health News:Postmenopausal Women's Sexual Dissatisfaction Not Linked to Heart Troubles 2Health News:Video: Senators and CEOs Urge Passage of Health IT Bill Now 2Health News:Video: Senators and CEOs Urge Passage of Health IT Bill Now 3Health News:China Nepstar Chain Drugstore Awarded Prestigious Title of '2007 Best Drugstore Chain in China' by China Drugstore Magazine 2Health News:China Nepstar Chain Drugstore Awarded Prestigious Title of '2007 Best Drugstore Chain in China' by China Drugstore Magazine 3Health News:Open Letter to Presidential Candidates on State Health Care Reform 2Health News:Haemacure Discloses Positive Results of a preclinical study of its fibrin sealant in adhesion prevention and opens a new opportunity in a market with a significant unmet medical need 2Health News:Haemacure Discloses Positive Results of a preclinical study of its fibrin sealant in adhesion prevention and opens a new opportunity in a market with a significant unmet medical need 3
(Date:6/2/2015)... June 02, 2015 Research and Markets( http://www.researchandmarkets.com/research/ctd7zx/europe ) ... - Growth, Trends And Forecasts (2014 - 2019)" report ... dominated by the Germany . This is ... nations such as Poland are the ... equipment can be segmented on the basis of Product (Film ...
(Date:6/2/2015)... June 02, 2015 Research and Markets ... the "Laboratory Centrifuges - Global Strategic Business ... Annual estimates and forecasts are provided for the ... analysis is provided for these markets. Market data ... research. Company profiles are primarily based on public ...
(Date:6/2/2015)... and Markets ( http://www.researchandmarkets.com/research/g5r2nj/surgical_incision ) has announced the addition of ... report to their offering. The report provides ... , Japan , Europe ... , and Rest of World. This report ... Million by the following Product Segments: Stapler Products (Internal Stapler, ...
Breaking Medicine Technology:Europe Mammography Market Report 2014-2019 - Growth, Trends And Forecasts 2Laboratory Centrifuges - Global Strategic Business Report 2014-2020: Developed Markets Slowdown, While Emerging Markets Surge 2Surgical Incision Closures - Global Strategic Business Report 2015 2
... Pharmaceutical Inc. (NYSE AMEX: CBP ) ("China Botanic" ... products, bio-pharmaceuticals and Traditional Chinese Medicines ("TCM") in China, today ... F irst Quarter 201 ... increased 24.4% year over year to $28.1 million Gross ...
... Pa., March 16, 2012  Kensey Nash Corporation (NASDAQ: ... entered into a settlement agreement with St. Jude Medical ... to the Angio-Seal vascular closure device licenses, as well ... agreement, the companies also agreed to extend their collagen ...
Cached Medicine Technology:China Botanic Reports First Quarter Fiscal 2012 Results 2China Botanic Reports First Quarter Fiscal 2012 Results 3China Botanic Reports First Quarter Fiscal 2012 Results 4China Botanic Reports First Quarter Fiscal 2012 Results 5China Botanic Reports First Quarter Fiscal 2012 Results 6China Botanic Reports First Quarter Fiscal 2012 Results 7China Botanic Reports First Quarter Fiscal 2012 Results 8Kensey Nash Announces Mediated Settlement With St. Jude Medical in Angio-Seal License Disputes and 5 Year Extension and Expansion of Collagen Supply Agreement 2Kensey Nash Announces Mediated Settlement With St. Jude Medical in Angio-Seal License Disputes and 5 Year Extension and Expansion of Collagen Supply Agreement 3Kensey Nash Announces Mediated Settlement With St. Jude Medical in Angio-Seal License Disputes and 5 Year Extension and Expansion of Collagen Supply Agreement 4Kensey Nash Announces Mediated Settlement With St. Jude Medical in Angio-Seal License Disputes and 5 Year Extension and Expansion of Collagen Supply Agreement 5Kensey Nash Announces Mediated Settlement With St. Jude Medical in Angio-Seal License Disputes and 5 Year Extension and Expansion of Collagen Supply Agreement 6
Kevorkian Endocervical Curette is a stainless-steel curette with a basket. It is narrow tipped for sampling without dilation....
Available in 5, 8 and 12 mm bite, with and without teeth....
...
...
Medicine Products: